The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening

被引:8
|
作者
Aitken, Clare A. [1 ]
Holtzer-Goor, Kim M. [2 ]
Uyterlinde, Anne [3 ]
van den Brule, Adriaan J. C. [4 ]
van der Linden, Hans C. [4 ]
Huijsmans, Cornelis J. [4 ]
de Kok, Inge M. C. M. [1 ]
van Kemenade, Folkert J. [5 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
[2] Dutch Natl Inst Publ Hlth & Environm, Ctr Populat Screening, Bilthoven, Netherlands
[3] Facilitaire Samenwerking Bevolkingsonderzoeken, Utrecht, Netherlands
[4] Jeroen Bosch Hosp, Pathol DNA, Shertogenbosch, Netherlands
[5] Erasmus MC Univ Med Ctr, Dept Pathol, Rotterdam, Netherlands
关键词
hrHPV screening; cervical cytology; cervical cancer screening;
D O I
10.1177/0969141319864991
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective Several studies have shown that there is an upward shift in the classification of cervical cytology when high-risk human papillomavirus (hrHPV) status is known to be positive. The Netherlands implemented primary hrHPV screening with reflex cytology as the primary screening test in 2017. Prior to implementation of the new programme, we investigated whether knowledge of hrHPV status influences cytology rating. Methods Using a set of 200 cytology slides that had been previously tested, two pairs of cytotechnicians rated 100 slides per pair twice: first without knowledge of hrHPV status and then, after a wash-out period of two months, with knowledge of hrHPV status. Results We found that hrHPV positive slides were more likely to be rated up over the referral threshold (i.e. from negative for intraepithelial lesion or malignancy to atypical squamous cells of undetermined significance+) than hrHPV negative slides at the second review when hrHPV status was known (relative risk = 3.2; 95% confidence interval: 1.3-7.9). Conclusions If the same upward shift in ratings were to be observed in the national programme, it may have implications for referrals of women with low-grade lesions.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [21] Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions
    El-Zein, Mariam
    Bouten, Sheila
    Abdrabo, Lina Sobhi
    Siblini, Aya
    Louvanto, Karolina
    Franco, Eduardo
    Ferenczy, Alex
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2023, 27 (01) : 12 - 18
  • [22] The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital
    Choi, Jung-Woo
    Kim, Younghye
    Lee, Ju-Han
    Kim, Young-Sik
    CANCER CYTOPATHOLOGY, 2016, 124 (02) : 144 - 152
  • [23] The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
    So, Kyeong A.
    Kim, Mi Jung
    Lee, Ki-Heon
    Lee, In-Ho
    Kim, Mi Kyung
    Lee, Yoo Kyung
    Hwang, Chang-Sun
    Jeong, Mi Seon
    Kee, Mee-Kyung
    Kang, Chun
    Cho, Chi Heum
    Kim, Seok Mo
    Hong, Sung Ran
    Kim, Ki Tae
    Lee, Won-Chul
    Park, Jong Sup
    Kim, Tae Jin
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1313 - 1320
  • [24] Quality control for normal liquid-based cytology: Rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?
    Depuydt, Christophe E.
    Arbyn, Marc
    Benoy, Ina H.
    Vandepitte, Johan
    Vereecken, Annie J.
    Bogers, Johannes J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (9B) : 4051 - 4060
  • [25] Value of high-risk HPV-DNA testing in the triage of ASCUS
    Silverloo, Irene
    Andrae, Bengt
    Wilander, Erik
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (09) : 1006 - 1010
  • [26] Mode of delivery does not have a relationship with high-risk HPV positivity
    Sel, G.
    Barut, A.
    Ozmen, U.
    Akdemir, A. Y.
    Harma, S.
    Aynali, B.
    Harma, M.
    Harma, M., I
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2020, 47 (04): : 541 - 545
  • [27] The impact on women's health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium
    Tjalma, Wiebren A. A.
    Kim, Emily
    Vandeweyer, Katleen
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 212 : 171 - 181
  • [28] Women with both p16INK4a and high-risk HPV positivity are candidates for intensified triage.
    Mehrotra, Swati
    McGlennen, Ron
    Pambuccian, Stefan E.
    Setty, Suman
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (03) : 469 - 469
  • [29] HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
    Richardson, Lyndsay Ann
    El-Zein, Mariam
    Ramanakumar, Agnihotram V.
    Ratnam, Samuel
    Sangwa-Lugoma, Ghislain
    Longatto-Filho, Adhemar
    Cardoso, Marly Augusto
    Coutlee, Francois
    Franco, Eduardo L.
    CANCER CYTOPATHOLOGY, 2015, 123 (12) : 745 - 754
  • [30] HPV testing with cytology triage for cervical cancer screening in routine practice
    Louvanto, Karolina
    Chevarie-Davis, Myriam
    Ramanakumar, Agnihotram Venkata
    Franco, Eduardo Luis
    Ferenczy, Alex
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (05) : 474.e1 - 474.e7